Published on 20 Dec 2022 on Zacks via Yahoo Finance
QuidelOrtho's (QDEL) Myocardial Infarction Test Cleared in Canada
QuidelOrtho Corporation QDEL recently announced that its TriageTrue High-Sensitivity Troponin I (hsTnl) Test on the Quidel Triage MeterPro had been approved for use in Canada by Health Canada. Per the company, the innovative test will likely achieve high sensitivity and precision when used with the Quidel Triage MeterPro platform.
However, it is worth mentioning that the Quidel Triage MeterPro is a high-performance, comprehensive testing platform with the currently smallest footprint analyzer, which can aid in the diagnosis of myocardial infarction.
The latest regulatory approval is likely to significantly boost QuidelOrtho’s immunoassay business.